Pubblicazioni

Long-term response to crizotinib in a 17-year-old boy with treatment-naÃ¯ve ALK-positive non-small-cell lung cancer

2022 - CANCER REPORTS

Megaro, Giacomina; Miele, Evelina; Spinelli, Gian Paolo; Alessi, Iside; Del Baldo, Giada; Cozza, Raffaele; Russo, Ida; De Pasquale, Maria Debora; Cefalo, Maria Giuseppina; TomÃ , Paolo; Carai, Andrea; Di Ruscio, Valentina; De Ioris, Maria Antonietta; Mastronuzzi, Angela

Mixed Pulmonary Adenocarcinoma and Atypical Carcinoid: A Report of Two Cases of a Non-codified Entity With Biological Profile

2021 - FRONTIERS IN MOLECULAR BIOSCIENCES

Parente, P; Rossi, A; Sparaneo, A; Fabrizio, Fp; Centonza, A; Taurchini, M; Mazza, T; Cassano, M; Miscio, G; Centra, F; Ferretti, Gm; Di Micco, Cm; Graziano, P; Muscarella, La

Re-irradiation in lung disease by SBRT. A retrospective, single institutional study

2018 - RADIATION ONCOLOGY

Caivano, D.; Valeriani, M.; De Matteis, S.; Bonome, P.; Russo, I.; De Sanctis, V.; Minniti, G.; Osti, M. F.

Optimized immunohistochemistry using the D5F3 antibody provides a reliable test for identification of ALK-positive lung adenocarcinomas

2017 - VIRCHOWS ARCHIV

Vinciguerra, Gian Luca Rampioni; Scarpino, Stefania; Pini, Benedetto; Cippitelli, Claudia; Fochetti, Flavio; Ruco, Luigi

High prevalence of ALK+/ROS1+ cases in pulmonary adenocarcinoma of adoloscents and young adults

2016 - LUNG CANCER

Scarpino, Stefania; RAMPIONI VINCIGUERRA, GIAN LUCA; DI NAPOLI, Arianna; Fochetti, Flavio; Uccini, Stefania; Iacono, Daniela; Marchetti, Paolo; Ruco, Luigi